57th Annual Pittsburgh Ophthalmology Society Meeting
This course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field. For example, clinical trials and other evidence in the peer-reviewed literature over the past few years have changed the approach to managing cataract including IOL technology and femtosecond laser cataract surgery, corneal disease including dry eye disease, keratoplasty, and collagen cross linking, glaucoma, and minimally invasive glaucoma surgical devices, as well as diabetic retinopathy, macular degeneration, and retinal vein occlusions. This course also includes legislative updates as it pertains to Ophthalmologists and their practice.
Learning Objectives
At the conclusion of this meeting, participants should be able to:
- Update their knowledge of diagnosis and treatment of common and rare ophthalmic diseases.
- Identify major advances in key areas of cutting-edge research and technology in Ophthalmology.
- Identify (appropriately) subsets of patients who may benefit from new treatment paradigms, diagnostic testing, or surgical interventions.
- Incorporate new treatment paradigms, diagnostic approaches, and surgical techniques into current clinical practice.
- Review, modify, and hone surgical skills and approaches to specific eye problems and clinical situations.
- Develop strategies to identify and address their own individual professional practice gaps.
- Recognize the indications for using the AREDS2 supplements that contain lutein/zeaxanthin
- Understand that cataract surgery does not increase the risk of progression to late AMD in persons with AMD
- Provide data on the use of fenofibrate for the treatment of diabetic retinopathy
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Allegheny General Hospital and the Pittsburgh Ophthalmology Society.
Allegheny General Hospital designates this live activity for a maximum of 7.0 AMA PRA Category 1
Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance